In the last 3 months. On the site you’ll find the news from the last 3 months. The older ones only have the title and a link, in file by topicsIt’s a support website for people with multiple myeloma. It aims to keep things simple and clear. MielomaAI As you may find.
Collected from Portuguese newspapers, Google News (PT, EN, ES, FR) and associations and scientific societies. They are on the website 197 news: only from the last 3 months. The older ones are only shown with the title and link, in file by topicsAnd research and the MielomaAI You continue to find them. Always consult the original news article and speak with your doctor before drawing conclusions about your case. Last update: November 17, 2026, 3:21 PM.
Tuesday, November 17
Photon-Counting CT Improves Image Quality and Cuts Radiation Dose in MyelomaBioengineer.org · 14:05 OutrasA retrospective comparative study shows photon-counting computed tomography delivers higher image quality and reduced radiation doses in multiple myeloma patients.
- Pfizer Multiple Myeloma Education GrantOncodaily · 10:41 Outras
Cobertura jornalística abrangente e atualizada, reunida a partir de fontes em todo o mundo pelo Google News.
Hi everyone, Recently my dad got diagnosed with myeloma. My dad and the rest of my family live in New Zealand and I live in Canada. I’ll be completing the Ironman in Ottawa 2027 to raise awareness for treatment for Myeloma. I’ll be documenting the trainingFacebook (Internacional) · 03:22 Doentes e associaçõesInternacional
Monday, 16/11
Etentamig in Relapsed/Refractory Multiple Myeloma: Pooled Phase 1 Data of an Investigational BCMA Bispecific AntibodyNational Institutes of Health (NIH) | (.gov) (EUA) · 23:37 InvestigaçãoEUA- Targeting the NFIL3-MYC Axis Overcomes Therapy Resistance in High-Risk Multiple MyelomaBioengineer.org (Reino Unido) · 22:49 TratamentosReino Unido
Cobertura jornalística abrangente e atualizada, reunida a partir de fontes em todo o mundo pelo Google News.
Published American recommendations for the management of renal transplantation in patients with plasmacytic disorders.InternationalMy Hematologia · 5 Sep 2025This article discusses how kidney transplantation can be an option for people with multiple myeloma and other diseases that damage the kidneys, but it still presents challenges. Read more →
Viviana was diagnosed with myeloma in 2024 and was told it could be treated but that there wasn't a cure. She'd previously been living with monoclonal gammopathy of undetermined significance (MGUS), a blood condition that can develop into blood cancer.Facebook (Internacional) · 19:00 Doentes e associaçõesInternacional
Myeloma Paper of the Day, November 16th, Suggested by Robert OrlowskiOncodaily (Reino Unido) · 18:18 OutrasReino UnidoMyeloma Paper of the Day, November 16th, Suggested by Robert Orlowski / Abhishek Gaur, Ankita Gupta, BMC Cardiovascular Disorders, Brendon Staruk, cancer,
Ben Derman։ Top 10 Myeloma Abstracts to Be Presented at ASH 2026Oncodaily · 18:05 InvestigaçãoBen Derman։ Top 10 Myeloma Abstracts to Be Presented at ASH 2026 / ASCO, ASH 2026, Ben Derman, cancer, CAR-T, DARA, Daratumumab, Lenalidomide, Mount Sinai,
MRD Ready to Guide Multiple Myeloma Treatment Decisions?MedPage Today · 17:32 Tratamentos'MRD is becoming a very valuable tool, but it's not an exclusive tool,' says expert
Next-Generation Multiple Myeloma Therapies Market to ReachopenPR.com · 16:44 TratamentosNovember 16 2026 Multiple myeloma treatment is expanding across antibody combinations CAR T cell therapies and newer immune modifying drugs Recent U S approvals have brought some options into earlier treatment lines while new subcutaneous formulations are changing how antibody ...
https://rarecancernews.com/news/under-the-skin-myeloma-treatment-linked-better-survival-study/ Interesting article.Facebook (Internacional) · 16:42 Doentes e associaçõesInternacional
Tempest acquires rights to experimental myeloma treatmentRare Cancer News · 16:28 TratamentosTempest Therapeutics has exercised an option to obtain rights to develop and commercialize an experimental treatment for myeloma.
Tocantins incorporates high-cost medication into the treatment of multiple myeloma.Surgiu (Brazil) · 16:18 Access and public healthBrazilPT
The Tocantins State Government is expanding oncological treatment by incorporating a high-cost medication.Agência Tocantins (Brazil) · 14:27 Access and public healthBrazilPTThe first administration of daratumumab was performed on a patient with multiple myeloma attended at the HGP.
Sanofi and the Alliance Pharmaceutical PanCanadian sign a letter of intent for Sarclisa® (isatuximab), a further step towards public access for newly diagnosed patients with multiple myeloma who are not eligible for a transplant.PR Newswire Canada (Canada) · 14:15 TreatmentsCan you provide the French text you want me to translate?FR/CNW/ -- Sanofi announced today the happy conclusion of negotiations with the Canadian Alliance Pharmaceutical (CPP), marked by the signing of a...
Sanofi and the pan-Canadian Pharmaceutical Alliance sign Letter of Intent for Sarclisa®(isatuximab), a step toward public access for newly diagnosed, transplant-ineligible multiple myeloma patientsPR Newswire Canada (Canadá) · 14:15 Doentes e associaçõesCanadá
Lola Manterola, from CRIS Against Cancer, Receives Research Award at the Woman 2026 Awards: the woman who turned her experience with cancer into an opportunity for thousands of patients.Woman Madame Figaro · 12:41 Patients and associationsESMultiple myeloma survivor, has turned his experience with the disease into a firm commitment to drive oncology research and give hope to thousands of patients. For them, it is our 2026 Woman Awards Research Prize.
Teclistamab Plus Daratumumab in Multiple Myeloma: FDA Adverse Event Reporting System AnalysisOncodaily · 11:23 TratamentosTeclistamab Plus Daratumumab in Multiple Myeloma: FDA Adverse Event Reporting System Analysis / BCMA, BCMA × CD3 bispecific antibody, Daratumumab, FDA
Pablo Sánchez, singer from La Raíz, returns after cancer with a novel: “Now I need to write to remain.Levante-EMV · 10:10 Patients and associationsESThe musician from Gandia, in complete remission from his multiple myeloma which had taken him away from the stage, publishes on November 24th ‘At the Shore of Krakatoa’, a fictional story born during his treatment.
MM’s Vulnerability to CAR T Was a Happy Surprise: Nikhil C. Munshi, MDThe American Journal of Managed Care® (AJMC®) (EUA) · 00:11 TratamentosEUAA single chimeric antigen receptor (CAR) T-cell infusion can clear heavily pretreated myeloma in 2 weeks, highlighting the immune system’s adaptability.
Can You Recognize the Oil Droplet Appearance? Multiple well-defined, punched-out skull lesions create a distinctive radiological pattern. Can you identify the underlying haematological malignancy? Hint: Think of a plasma-cell disorder associated with osteolFacebook (Internacional) · 00:00 OutrasInternacional
Sunday, November 15
Rafat Abonour: My Top 10 Interventional Abstracts in Multiple Myeloma and AL Amyloidosis Ahead of ASH 2026Oncodaily · 20:49 InvestigaçãoRafat Abonour: My Top 10 Interventional Abstracts in Multiple Myeloma and AL Amyloidosis Ahead of ASH 2026 / ASH 2026, ASH26, cancer, multiple myeloma,
Al-Ola A. Abdallah: Four Emerging Research Highlights from ASH26Oncodaily · 18:52 InvestigaçãoAl-Ola A. Abdallah: Four Emerging Research Highlights from ASH26 / Al-Ola A Abdallah, ASH 2026, cancer care, Cancer research, Hematology, Myeloma, OncoDaily
Why Multiple Myeloma’s Standard of Care Could Change Again Within a YearCancerNetwork (EUA) · 18:05 TratamentosEUACancerNetwork is home to the journal Oncology & provides insights on the screening, early detection, diagnosis, treatment and prevention of cancers.
Myeloma Paper of the Day, November 15th, Suggested by Robert OrlowskiOncodaily · 14:45 OutrasMyeloma Paper of the Day, November 15th, Suggested by Robert Orlowski / Angela Dispenzieri, Blood Cancer Journal, cancer, Daniel G. Packard, David Dingli,
Saturday, November 14
Luciano Costa Shares His Top 10 Multiple Myeloma Abstracts at ASH 2026Oncodaily (EUA) · 18:15 Acesso e saúde públicaEUALuciano Costa Shares His Top 10 Multiple Myeloma Abstracts at ASH 2026 / American Society of Hematology (ASH), ASH 2026, cancer care, Cancer research,
- Secondary Gastric Plasmacytoma Mimicking Aggressive Gastric Lymphoma in Relapsed Multiple Myeloma: A Case ReportCureus (Reino Unido) · 13:41 OutrasReino Unido
Cobertura jornalística abrangente e atualizada, reunida a partir de fontes em todo o mundo pelo Google News.
Friday, November 13
CAR-NK Therapy for Multiple Myeloma: A Clinical Trial Success StoryHealth US News · 20:41 Doentes e associaçõesDiscover how an innovative CAR-NK cell therapy clinical trial led to complete remission for a patient facing relapsed multiple myeloma.
Six jobs for AI in myeloma care, from Prerna Mewawalla, M.D.Managed Healthcare Executive · 19:24 TratamentosOnly 19% of community oncologists use AI predictive models. Prerna Mewawalla, M.D., outlines six ways AI can already help in myeloma care.
REMS Certification and Team-Wide Training for Bispecific Administration in Multiple MyelomaCancerNetwork (EUA) · 15:05 Acesso e saúde públicaEUARalph V. Boccia, MD, FACP, explained who needs REMS certification and which care team members need training to deliver bispecific antibodies.
Warburg Trap Therapy Selectively Triggers Apoptosis in Multiple Myeloma Cells in VitroBioengineer.org · 14:25 TratamentosA laboratory study demonstrates that combining mitochondrial complex I inhibitors with proton ionophores selectively triggers apoptosis and disrupts energy balance in multiple myeloma cells in vitro.
Optimal Cytoreduction and Early Trial Referral in High-Risk Newly Diagnosed MyelomaCancerNetwork (EUA) · 13:08 Acesso e saúde públicaEUASaad Z. Usmani, MD, MBA, FACP, FASCO, discussed quadruplet induction, extended maintenance, and when a community clinician should call a myeloma center.
My Treatment Approach: Optimizing Treatment Strategies for Relapsed/Refractory Multiple MyelomaOncLive (EUA) · 13:00 TratamentosEUAMy Treatment Approach: Optimizing Treatment Strategies for Relapsed/Refractory Multiple Myeloma | OncLive Insights | OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Seminar in Coimbra brings together patients and specialists to discuss multiple myeloma and the role of CAR-T cellsHealthNews (Portugal) · 07:08 Patients and associationsPortugalPT
Clinical Nurse Specialist - Myeloma – Liverpooljobs24 (Reino Unido) · 07:07 OutrasReino UnidoClinical Nurse Specialist - Myeloma at The Clatterbridge Cancer Centre NHS Foundation Trust in Liverpool. £49387-£56515. Temporary Apply on jobs24 today.
Thursday, November 12th
Referral Before Salvage Therapy Keeps CAR T an Option in MyelomaTargeted Onc (EUA) · 22:08 TratamentosEUADuring a live event, Rushang Patel, MD, PhD, and participants discussed referral timing, bridging, and payer barriers that shape access to cellular therapy in early relapsed multiple myeloma.
Impressive Results of Trispecific Antibody in Myeloma Presented at EHA 2025 CongressTargeted Onc (EUA) · 22:00 InvestigaçãoEUARecent advancements in multiple myeloma treatment highlight the promise of trispecific antibodies like JNJ-5322, potentially enhancing patient outcomes significantly.
How Etentamig Stands Out From Other BCMA BispecificsTargeted Onc (EUA) · 22:00 TratamentosEUAPeter Voorhees, MD, explains how etentamig differentiates itself from other BCMA bispecifics for multiple myeloma through a strategic engineering choice: a low-affinity CD3 binding domain. By intentionally reducing this affinity, the design aims to mitigate severe cytokine release syndrome. It can also be given on an…
What Sustained MRD Negativity Can Settle About Stopping Myeloma MaintenanceCancerNetwork (EUA) · 21:08 InvestigaçãoEUASaad Z. Usmani, MD, MBA, FACP, FASCO, discussed the threshold he will act on in standard-risk disease, and the trial that would make the decision firmer.
‘Lady A’ Country Singer Charles Kelley, 45, Says Myeloma Treatment Is ‘Working Really Well’ but He Didn’t Expect So Much Pain: What Patients Should KnowSurvivorNet (Reino Unido) · 17:22 Doentes e associaçõesReino Unido"Lady A" country singer Charles Kelley, 45, says his multiple myeloma treatment is working, but he has been surprised by the physical toll, describing significant pain, body aches, and fatigue during his cancer journey.
CELMoDs as Holding and Bridging Therapy in Multiple MyelomaCancerNetwork (EUA) · 15:43 TratamentosEUAIn this segment, Dr. Joseph Mikhael and Dr. Scott Goldsmith explore the potential role of cereblon E3 ligase modulators (CELMoDs) as holding and bridging therapies for patients with multiple myeloma preparing for chimeric antigen receptor (CAR) T-cell therapy.
Lymphoma, Myeloma & Prostate CancerCure Today (EUA) · 15:00 Acesso e saúde públicaEUAFDA approves Mozobil for non-Hodgkin lymphoma and myeloma, and Degarelix for advanced prostate cancer.
EXCALIBER-RRMM Trial Results: MRD Negativity and Progression-Free Survival in Relapsed/Refractory Multiple MyelomaCancerNetwork (EUA) · 13:13 InvestigaçãoEUAIn this segment, Dr. Joseph Mikhael and Dr. Paul Richardson discuss findings from the phase 3 EXCALIBER-RRMM trial, which compared iberdomide plus daratumumab and dexamethasone with bortezomib plus daratumumab and dexamethasone in patients with relapsed/refractory multiple myeloma.
CELMoDs With CAR T-Cell Therapy and Bispecific Antibodies in Multiple MyelomaCancerNetwork (EUA) · 13:13 TratamentosEUAIn this segment, Dr. Joseph Mikhael and Dr. Scott Goldsmith discuss the potential role of cereblon E3 ligase modulators (CELMoDs) following chimeric antigen receptor (CAR) T-cell therapy and in combination with bispecific antibodies for multiple myeloma.
APCL brings together specialists and patients in Coimbra to discuss advances in multiple myelomaNews Farma (Portugal) · 11:39 Patients and associationsPortugalPTThe Portuguese Association Against Leukaemia (APCL) is holding a seminar dedicated to multiple myeloma (MM) on November 21st, between 09:30 and 17:20, at the Conservatório de Música de Coimbra School of Arts. The event brings together patients, caregivers, doctors, and other healthcare professionals, fostering dialogue…
- FDA Approval of Iberdomide Marks Historic Milestone in Multiple MyelomaCleveland Clinic (EUA) · 06:25 Acesso e saúde públicaEUA
Cobertura jornalística abrangente e atualizada, reunida a partir de fontes em todo o mundo pelo Google News.
Wednesday, 11/11
Real-World Teclistamab Shows Deep Responses in R/R Multiple Myeloma CohortCancerNetwork (EUA) · 20:08 TratamentosEUAIn a retrospective analysis, teclistamab produced response rates numerically higher than in MajesTEC-1, with missed doses not compromising outcomes.
Mehak Trehan: 10 Pivotal Myeloma Abstracts to Watch at ASH 2026Oncodaily (EUA) · 19:13 InvestigaçãoEUAMehak Trehan: 10 Pivotal Myeloma Abstracts to Watch at ASH 2026 / ASH 2026, cancer care, Cancer research, Hematology, Mehak Trehan, Myeloma, OncoDaily
How Is Telo Genomics (TSXV:TELO) Testing TELO-MRD Against clonoSEQ in Myeloma?Kalkine Media (Reino Unido) · 18:06 InvestigaçãoReino Unido
Doctor from Santa Rosa participates in immersion on the treatment of multiple myeloma in the United States.Jornal Noroeste (Brazil) · 17:00 TreatmentsBrazilPTThe event, held in an immersive course format, brought together teachers and specialist doctors in the field within a program that included lectures, visits to reference centers, and discussions about diagnostic and therapeutic approaches for multiple myeloma, a type of cancer that affects plasma cells in the bone marrow…
- Tempest Therapeutics Exercises Option to License Senlang’s CD7-Targeted Lentiviral In Vivo CAR-T Platform Following Initial Phase 1 Results with Lead BCMA/GPRC5D CandidateGlobeNewswire (Internacional) · 13:53 TratamentosInternacional
-Tempest secures exclusive global rights outside China to a targeted lentiviral platform and portfolio of in vivo CAR-T candidates -Lead BCMA/GPRC5D...
Real-world treatment patterns and clinical outcomes in relapsed/refractory multiple myeloma across Asia: a multicenter Asian Myeloma Network study (AMN010)Nature (Reino Unido) · 09:29 InvestigaçãoReino Unido
ALDH2 Suppresses Multiple Myeloma Progression by Restraining the E2F Signaling PathwayBioengineer.org · 08:30 Outras
Legend Biotech shares tumble as Carvykti outlook overshadows profitBamboo Works · 04:23 Tratamentos
